Suvorexant

Suvorexant (Cay-22911) is an analytical reference standard categorized as a diazepane sedative. Formulations containing suvorexant show abuse potential similar to zolpidem (Cay-15792) in recreational polydrug users with a history of sedative and psychedelic drug use. Suvorexant is regulated as a Schedule IV compound in the United States. This product is intended for use in analytical forensic applications.Formal Name: [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-methanone. CAS Number: 1030377-33-3. Molecular Formula: C23H23ClN6O2. Formula Weight: 450.9. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 12 mg/ml, DMF:PBS (pH 7.2) (1:9): 0.1 mg/ml, DMSO: 10 mg/ml, Ethanol: 0.3 mg/ml. lambdamax: 216, 258 nm. SMILES: CC1=CC=C(C(C(N2CCN(CC[C@H]2C)C3=NC4=C(O3)C=CC(Cl)=C4)=O)=C1)N5N=CC=N5. InChi Code: InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1. InChi Key: JYTNQNCOQXFQPK-MRXNPFEDSA-N.